Pretransplantation Direct-acting Antivirals Provides a Safe and Effective without Increase Recurrence of Hepatocellular Carcinoma in HCV-related HCC Patients

被引:0
|
作者
Yin, S. M. [1 ]
Chen, C. L. [1 ]
Lin, C. C. [1 ]
Wang, C. C. [1 ]
Wang, S. H. [1 ]
Liu, Y. W. [1 ]
Yong, C. C. [1 ]
Lin, T. L. [1 ]
Li, W. F. [1 ]
Lin, Y. H. [1 ]
Chan, Y-C [1 ]
Yeh, C-S [1 ]
机构
[1] Kaohsiung Chang Gung Mem Hosp, Gen Surg, Kaohsiung, Taiwan
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
O-59
引用
收藏
页码:42 / 43
页数:2
相关论文
共 50 条
  • [31] Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-Acting Antivirals
    Debes, Jose D.
    van Tilborg, Marjolein
    Groothuismink, Zwier M. A.
    Hansen, Bettina E.
    zur Wiesch, Julian Schulze
    von Felden, Johann
    de Knegt, Robert J.
    Boonstra, Andre
    GASTROENTEROLOGY, 2018, 154 (03) : 515 - +
  • [32] IMPACT OF DIRECT ACTING ANTIVIRALS ON HCV-RELATED HCC WAITLIST REGISTRATIONS AND RISING HCC INCIDENCE IN NATIONAL LIVER TRANSPLANT REGISTRY
    Gadiparthi, Chiranjeevi
    Siddique, Osama
    Cholankeril, Rosann
    Yoo, Eric R.
    Khan, Muhammad Ali
    Perumpail, Ryan B.
    Hu, Menghan
    Cholankeril, George
    Ahmed, Aijaz
    GASTROENTEROLOGY, 2017, 152 (05) : S1100 - S1100
  • [33] PIVKA II a useful biomarker for hepatocellular carcinoma in caucasian HCV cirrhotic patients treated with direct-acting antivirals
    Degasperi, E.
    De Monti, A.
    Perbellini, R.
    D'Ambrosio, R.
    Lunghi, G.
    Ceriotti, F.
    Perego, A.
    Orsini, C.
    Borghi, M.
    Iavarone, M.
    Bruccoleri, M.
    Sangiovanni, A.
    Lampertico, P.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : E10 - E11
  • [34] Predicting Hepatocellular Carcinoma Risk in Patients with Chronic HCV Infection and a Sustained Virological Response to Direct-Acting Antivirals
    D'Ambrosio, Roberta
    Degasperi, Elisabetta
    Lampertico, Pietro
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 713 - 739
  • [35] Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan
    Chi, Chen-Ta
    Chen, Chi-Yi
    Su, Chien-Wei
    Chen, Po-Yueh
    Chu, Chi-Jen
    Lan, Keng-Hsin
    Lee, I-Cheng
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2021, 54 (03) : 385 - 395
  • [36] INCIDENCE OF HEPATOCELLULAR CARCINOMA AND EXTRAHEPATIC CANCERS AMONG HCV-INFECTED PATIENTS IN THE ERA OF DIRECT-ACTING ANTIVIRALS
    Wang, W.
    Lo Re, I. I. I., V
    Xiao, H.
    Brown, J.
    Yi, G.
    Park, H.
    VALUE IN HEALTH, 2018, 21 : S12 - S13
  • [37] Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals
    Lleo, Ana
    Aglitti, Andrea
    Aghemo, Alessio
    Maisonneuve, Patrick
    Brunoa, Savino
    Persico, Marcello
    Rendina, Maria
    Ciancio, Alessia
    Lampertico, Pietro
    Brunetto, Maurizia R.
    Di Marco, Vito
    Zuin, Massimo
    Andreone, Pietro
    Villa, Erica
    Troshina, Giulia
    Degasperi, Elisabetta
    Coco, Barbara
    Calvaruso, Vincenza
    Giorgini, Alessia M.
    Conti, Fabio
    Di Leo, Alfredo
    Marzi, Uca
    Boccaccio, Vincenzo
    Bollani, Simona
    Colombo, Massimo
    Marzi, Luca
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (02) : 310 - 317
  • [38] DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS
    Buonfiglioli, F.
    Conti, F.
    Andreone, P.
    Crespi, C.
    Foschi, F. G.
    Lenzi, M.
    Mazzella, G.
    Verucchi, G.
    Brillanti, S.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S215 - S215
  • [39] Development and validation of an artificial intelligence PIVKA-II-based model for the prediction of hepatocellular carcinoma development in patients with HCV-related cirrhosis successfully treated with direct-acting antivirals
    Caviglia, G. P.
    Fariselli, P.
    D'Ambrosio, R.
    Degasperi, E.
    Troshina, G.
    Nicolosi, A.
    Saracco, G. M.
    Lampertico, P.
    Ciancio, A.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S165 - S165
  • [40] Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals
    Cabral, Loraine Kay D.
    Grisetti, Luca
    Pratama, Muhammad Yogi
    Tiribelli, Claudio
    Pascut, Devis
    CANCERS, 2022, 14 (11)